HTG Molecular Diagnostics Inc (HTGMQ)
0.0025
0.00 (0.00%)
USD |
OTCM |
May 10, 16:00
HTG Molecular Diagnostics 1 Year Total Returns (Daily): -99.91% for May 10, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 10, 2024 | -99.91% |
May 09, 2024 | -99.90% |
May 08, 2024 | -99.94% |
May 07, 2024 | -99.90% |
May 06, 2024 | -99.90% |
May 03, 2024 | -99.90% |
May 02, 2024 | -99.90% |
May 01, 2024 | -99.89% |
April 30, 2024 | -99.90% |
April 29, 2024 | -99.90% |
April 26, 2024 | -99.91% |
April 25, 2024 | -99.95% |
April 24, 2024 | -99.92% |
April 23, 2024 | -99.92% |
April 22, 2024 | -99.92% |
April 19, 2024 | -99.92% |
April 18, 2024 | -99.96% |
April 17, 2024 | -99.95% |
April 16, 2024 | -99.95% |
April 15, 2024 | -99.95% |
April 12, 2024 | -99.93% |
April 11, 2024 | -99.93% |
April 10, 2024 | -99.94% |
April 09, 2024 | -99.94% |
April 08, 2024 | -99.94% |
Date | Value |
---|---|
April 05, 2024 | -99.94% |
April 04, 2024 | -99.94% |
April 03, 2024 | -99.95% |
April 02, 2024 | -99.94% |
April 01, 2024 | -99.94% |
March 28, 2024 | -99.96% |
March 27, 2024 | -99.96% |
March 26, 2024 | -99.96% |
March 25, 2024 | -99.93% |
March 22, 2024 | -99.91% |
March 21, 2024 | -99.91% |
March 20, 2024 | -99.92% |
March 19, 2024 | -99.91% |
March 18, 2024 | -99.91% |
March 15, 2024 | -99.92% |
March 14, 2024 | -99.92% |
March 13, 2024 | -99.92% |
March 12, 2024 | -99.92% |
March 11, 2024 | -99.95% |
March 08, 2024 | -99.96% |
March 07, 2024 | -99.96% |
March 06, 2024 | -99.96% |
March 05, 2024 | -99.96% |
March 04, 2024 | -99.96% |
March 01, 2024 | -99.96% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-99.98%
Minimum
Dec 21 2023
391.6%
Maximum
May 22 2023
-48.49%
Average
-67.48%
Median
Jun 30 2023
1 Year Total Returns (Daily) Benchmarks
Viveve Medical Inc | -99.40% |
Minerva Surgical Inc | -99.98% |
Stereotaxis Inc | 21.79% |
Electromed Inc | 44.26% |
Myomo Inc | 651.0% |